Loading…
Cardinal Health, Inc. is projected to rise to $288.36 by 2027, a +21% move from its current price of $238.94. CAH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 5 | $236.09 | $238.96 | $241.86 | +0.01% |
| Jul 6 | $234.93 | $238.98 | $243.10 | +0.02% |
| Jul 7 | $234.04 | $238.99 | $244.05 | +0.02% |
| Jul 8 | $233.30 | $239.01 | $244.86 | +0.03% |
| Jul 9 | $232.66 | $239.03 | $245.58 | +0.04% |
| Jul 10 | $232.07 | $239.05 | $246.23 | +0.05% |
| Jul 11 | $231.54 | $239.07 | $246.84 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $231.54 | $239.07 | $246.84 | +0.05% |
| Week 2 | $228.62 | $239.20 | $250.26 | +0.11% |
| Week 3 | $226.43 | $239.32 | $252.96 | +0.16% |
| Week 4 | $224.61 | $239.45 | $255.27 | +0.21% |
| Week 5 | $223.04 | $239.58 | $257.34 | +0.27% |
| Week 6 | $221.65 | $239.71 | $259.25 | +0.32% |
| Week 7 | $220.38 | $239.84 | $261.02 | +0.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It serves hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
It manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Cardinal Health, Inc. (CAH) is currently priced at $233.01 with a market capitalization of $54.57B. It ranks 299 among companies by market capitalization.
The price outlook remains broadly bullish over the longer horizon, with forecasted averages rising from $233.01 in 2026 to $281.94 in 2027, $304.40 in 2028, and $348.97 in 2029, then $440.81 in 2030. Max forecasts rise to $601.33 in 2030, with further upside implied through 2040 and 2050 (e.g., max $4,083.68 in 2050).
Forecasted ROIs advance from 0% in 2026 to 21% in 2027, 30.6% in 2028, 49.8% in 2029, 89.2% in 2030, and up to 971.6% by 2050, with a generally bullish sentiment across the horizon.
A major floor 24.6% below — a decisive break under it would weaken the trend.
The nearest floor, 18.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.3% above — clearing it would confirm fresh momentum.
Key CAH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CAH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $237.67 | Buy | $236.95 | Buy |
| MA 10 | $232.95 | Buy | $233.27 | Buy |
| MA 20 | $224.79 | Buy | $225.85 | Buy |
| MA 50 | $207.57 | Buy | $215.53 | Buy |
| MA 100 | $212.24 | Buy | $210.14 | Buy |
| MA 200 | $201.04 | Buy | $198.74 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 76.56 | Sell |
| Stoch RSI (14) | 84.42 | Sell |
| CCI (20) | 101.73 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.92 | Buy |
| ROC (12) | 5.54 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.59 | Buy |
| Awesome (5,34) | 23.88 | Buy |
| Ultimate (7,14,28) | 83.06 | Sell |
| Momentum (10) | 12.66 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 239.70 | Sell |
| ADX (14) | 39.29 | Buy |
| ATR (14) | 2.45 | Info |
The 30-day technical picture is bullish. RSI14 sits at 80, supporting positive near-term momentum.
The stock trades above the 50-day simple moving average at $204.51 and above the 200-day moving average at $198.46, indicating sustained upward pressure. Near-term support is at $182.56, with resistance at $233.01, forming a framework for upside potential.
The 30-day price range spans from $212.29 to $255.75, reflecting current volatility. Annualized volatility is 30%, underscoring the typical risk seen over a rolling one-month window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $182.50 | $238.94 | $292.78 | 0% | Neutral | |
| $236.06 | $288.36 | $368.35 | +21% | Bullish | |
| $251.65 | $313.14 | $410.76 | +31% | Bullish | |
| $282.03 | $356.35 | $477.35 | +49% | Bullish | |
| $352.37 | $451.23 | $615.29 | +89% | Bullish | |
| $397.16 | $514.78 | $713.02 | +115% | Bullish | |
| $449.13 | $588.70 | $826.98 | +146% | Bullish | |
| $480.76 | $636.79 | $906.09 | +167% | Bullish | |
| $482.84 | $645.91 | $930.04 | +170% | Bullish | |
| $544.62 | $735.43 | $1,070.72 | +208% | Bullish | |
| $848.70 | $1,195.29 | $1,823.57 | +400% | Bullish | |
| $1,693.63 | $2,558.12 | $4,183.26 | +971% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $182.50 | $238.94 | $282.80 | +0.00% |
| August 2026 | $201.85 | $236.59 | $283.55 | -0.98% |
| September 2026 | $204.35 | $240.61 | $290.50 | +1.70% |
| October 2026 | $204.53 | $241.78 | $293.76 | +0.48% |
| November 2026 | $199.94 | $237.15 | $289.67 | -1.92% |
| December 2026 | $200.45 | $238.51 | $292.78 | +0.57% |
Click any year to see its month-by-month CAH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CAH to range from $182.50 to $292.78 through 2026. The $238.94 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CAH price prediction for 2027 points to an average of $288.36 (low $236.06, high $368.35) — a potential gain of +21% on today's $238.94. Momentum favours further upside here.
In 2028, CAH is projected to trade between $251.65 and $410.76, averaging $313.14 — a potential gain of +31% from today's $238.94. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Cardinal Health, Inc.'s 2029 outlook centres on $356.35, within a $282.03 to $477.35 range. That is up +14% on the projected 2028 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2030, CAH could reach as high as $615.29, with a base case around $451.23 and support toward $352.37 — roughly +89% from $238.94. Buyers look set to stay in control over this stretch.
Expect CAH to range from $397.16 to $713.02 through 2031. The $514.78 average target implies a +115% move from current prices. That is up +14% on the projected 2030 average. Momentum favours further upside here.
The CAH price prediction for 2032 points to an average of $588.70 (low $449.13, high $826.98) — a potential gain of +146% on today's $238.94. Buyers look set to stay in control over this stretch.
In 2033, CAH is projected to trade between $480.76 and $906.09, averaging $636.79 — a potential gain of +167% from today's $238.94. That is up +8% on the projected 2032 average. Momentum favours further upside here.
Cardinal Health, Inc.'s 2034 outlook centres on $645.91, within a $482.84 to $930.04 range. That is up +1% on the projected 2033 average. That marks a +170% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CAH could reach as high as $1,070.72, with a base case around $735.43 and support toward $544.62 — roughly +208% from $238.94. Momentum favours further upside here.
Expect CAH to range from $848.70 to $1,823.57 through 2040. The $1,195.29 average target implies a +400% move from current prices. That is up +63% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CAH price prediction for 2050 points to an average of $2,558.12 (low $1,693.63, high $4,183.26) — a potential gain of +971% on today's $238.94. Momentum favours further upside here.
Investing $1,000 in CAH today (≈ 4.185151 CAH) could be worth
$10,706.11
+$9,706.11 (+971%) by 2050 · US Dollar
Based on the average projected CAH price of $2,558.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CAHwould be worth at today's price.
$1,000 invested in CAH on Jul 2, 2025 (≈ 6.173602 CAH) would be worth
$1,475.12
+$475.12 (+47.5%) today · 1.48× · US Dollar
Based on a CAH entry price of $161.98 vs. today's $238.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $234.75 | $1,017.85 | +1.8% |
| 1 month ago | $194.88 | $1,226.09 | +22.6% |
| 3 months ago | $214.05 | $1,116.28 | +11.6% |
| 6 months ago | $205.72 | $1,161.48 | +16.1% |
| 1 year ago | $161.98 | $1,475.12 | +47.5% |
| All time (5.0y) ago | $56.95 | $4,195.61 | +319.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CAH forecast.
Our base-case forecast reaches $480.00 around 2031.
Implied market cap at $480.00: $112.42B
The multi-year forecast paints a clear bullish trajectory, with the average price advancing from $233.01 in 2026 to $281.94 in 2027, then to $304.40 in 2028 and $348.97 in 2029. The 2030 average is projected at $440.81, delivering an 89.2% ROI, and continuing to rise to $500.64 by 2031 and beyond.
The forecast shows further upside to a 2040 average of $1,152.02 and a 2050 average of $2,496.86, with corresponding ROIs of 394.4% and 971.6%, respectively. The 2030 max is $601.33 and the 2050 max reaches $4,083.68, with bullish sentiment continuing through 2050.
Actual outcomes depend on market conditions and other factors; investors should consider the inherent uncertainty and potential downside risks in any long-term projection.
Tap a question to reveal the answer.
2030 forecast: min $344.13, avg $440.81, max $601.33; ROI 89.2%; sentiment BULLISH.
The forecast shows a bullish path from 2027 onward, with averages rising to $281.94 (2027), $304.40 (2028), $348.97 (2029), and $440.81 (2030). Long-run outlooks show higher averages and a max of $4,083.68 by 2050, with ROI up to 971.6%. These are forecasts, not guarantees.
Yes. The 2030 max forecast is $601.33, which is slightly above $600.
Current price is $233.01 and market cap is $54.57B. It is ranked 299.
RSI14 is 80 with bullish sentiment. The 30-day range is $212.29 to $255.75, with support at $182.56 and resistance at $233.01. Annualized volatility is 30%.
Cardinal Health, Inc. Community Discussion
0Share your Cardinal Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.